Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: group B: Group B patients will receive 4mcg of norepinephrine as intravenous bolus whenever the mean arterial pressure drops below 20% of baseline.
Control Intervention1: GROUPI: GROUP
Sponsors
Amrita Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Elective CS under spinal anaesthesia 2. Normal singleton pregnancy beyond 36 weeks gestation 3. ASA physical status 1 or 2 4. Weight 50-100 kg 5. Height 150-180 cm
Exclusion criteria
Exclusion criteria: 1.Allergy or hypersensitivity to norepinephrine 2.Any hypertensive disorders of pregnancy 3.Cardiovascular or cerebrovascular disease 4.Fetal abnormalities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the total dose of norepinephrine required to maintain maternal blood pressure when used as bolus or infusion in patients undergoing caesarean section under spinal anaesthesia.Timepoint: intraoperative period | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effects of bolus versus infusion of norepinephrine on incidence of bradycardia, hypertension ,nausea and vomiting in mother and foetal outcomes as assessed by APGAR score and umbilical vein pH.Timepoint: intraoperative period | — |
Countries
India
Contacts
Public ContactNitu PV
Amrita Institute of medical Sciences
Outcome results
None listed